7.470 3.61%

Research Hotspot

Click Each Keyword to Figure Out More

Molecular Therapy - Journal Impact

The Journal Impact 2019-2020 of Molecular Therapy is 7.470, which is just updated in 2020. Compared with historical Journal Impact data, the Metric 2019 of Molecular Therapy grew by 3.61% . The Journal Impact Quartile of Molecular Therapy is Q1. The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The Journal Impact measures the average number of citations received in a particular year (2019) by papers published in the journal during the two preceding years (2017-2018). Note that 2019 Journal Impact are reported in 2020; they cannot be calculated until all of the 2019 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of Molecular Therapy.

10.0 ~ 10.5


4/6


Molecular Therapy - Journal Impact Prediction System

67% scientists expect Molecular Therapy Journal Impact 2020 will be in the range of 10.0 ~ 10.5. Journal Impact Prediction System provides an open, transparent, and straightforward platform to help academic researchers Predict future Metric and performance through the wisdom of crowds. Journal Impact Prediction System displays the exact community-driven Metric without secret algorithms, hidden factors, or systematic delay.

Molecular Therapy Journal Impact Prediction System - Metric and Trend
  • Article Volume 2017 263
  • Article Volume 2016 248
  • Article Volume 2015 225
  • ISSN
  • 15250024, 15250016
  • Open Access
  • Publisher
  • Cell Press
  • Country/Region
  • United States
  • History
  • Categories
  • Drug Discovery (Q1), Genetics (Q1), Medicine (miscellaneous) (Q1), Molecular Biology (Q1), Molecular Medicine (Q1), Pharmacology (Q1)

Molecular Therapy - ISSN

The ISSN of Molecular Therapy is 15250024, 15250016. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Molecular Therapy - ISSN

Molecular Therapy - Subscription (non-OA) Journal

Molecular Therapy is a Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Molecular Therapy - Open Access

Molecular Therapy - Publisher

Molecular Therapy is published by Cell Press, which is located in the United States. The Publication History of Molecular Therapy covers 2000-ongoing.

Molecular Therapy - Publisher

Molecular Therapy - Categories

Molecular Therapy is a peer-reviewed scientific journal. The scope of Molecular Therapy covers Drug Discovery (Q1), Genetics (Q1), Medicine (miscellaneous) (Q1), Molecular Biology (Q1), Molecular Medicine (Q1), Pharmacology (Q1).

Molecular Therapy - Categories

Molecular Therapy - Journal Factors

It is impossible to get a true picture of impact using a single Metric alone, so a basket of factors is needed to support informed decisions. In addition to Abbreviation, Acceptance Rate, Review Speed, Research Hotspot and Template, several advanced Journal Factors including Citescore, H-Index, Self-Citation Ratio, SJR (SCImago Journal Rank Indicator) and SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the Molecular Therapy.

Molecular Therapy - Journal Metric

Journal Ranking